Why the study?
Do biological markers such as lipid parameters and myocardial necrosis enzymes predict the no-reflow phenomenon after primary PCI in patients with STEMI?
Do biological markers such as lipid parameters and myocardial necrosis enzymes predict the no-reflow phenomenon after primary PCI in patients with STEMI?
Elevated lipid parameters and very high levels of myocardial necrosis enzymes may predict the development of the no-reflow phenomenon after primary PCI in STEMI patients.
May flag no-reflow risk in STEMI; hypothesis-generating and should not yet change practice.
Lipid parameters along with the biological markers of myocardial necrosis play an essential role in highlighting the patient at an increased risk of developing the no-reflow phenomenon from an STEMI. This phenomenon is due to primary PCI failure of blood flow in the coronary microcirculation, although the artery involved in the infarction is disintegrated.
No takes yet. Share an insight, caveat, or question.
Pantea-Roșan et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: